Evolutionary aspects of cancer resistance

Seminars in Cancer Biology

Volumn 25, Issue , 2014, Pages 10-14

  Klein, George ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cancer resistance; Fibroblasts; Microenvironment; Neighbor suppression

Indexed keywords

AGING; APOPTOSIS; CANCER ASSOCIATED FIBROBLAST; CANCER CELL; CANCER CONTROL; CANCER GROWTH; CANCER INCIDENCE; CANCER INHIBITION; CANCER RESISTANCE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL DIFFERENTIATION; DNA REPAIR; EPIGENETICS; FIBROBLAST; GENE ACTIVATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE INACTIVATION; GENETIC ANALYSIS; GENOTYPE; GERIATRIC PATIENT; HUMAN; IN VITRO STUDY; MOLECULAR MECHANICS; NONHUMAN; REVIEW; STROMA CELL; TUMOR MICROENVIRONMENT; ANIMAL; CELL ADHESION; CELL COMMUNICATION; GENETIC PREDISPOSITION; GENETICS; MOLECULAR EVOLUTION; NEOPLASM; ONCOGENE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL ADHESION; CELL COMMUNICATION; EVOLUTION, MOLECULAR; FIBROBLASTS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; ONCOGENES; TUMOR MICROENVIRONMENT;

EID: 84897482366     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2014.01.001     Document Type: Review

References (25)

1. Klein G. Epigenetics: surveillance team against cancer. Nature 2005, 434(7030):150.
2. Seluanov A., Hine C., Azpurua J., Feigenson M., Bozzella M., Mao Z., et al. Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat. Proc Natl Acad Sci USA 2009, 106(46):19352-19357.
3. Gorbunova V., Hine C., Tian X., Ablaeva J., Gudkov A.V., Nevo E., et al. Cancer resistance in the blind mole rat is mediated by concerted necrotic cell death mechanism. Proc Natl Acad Sci USA 2012, 109(47):19392-19396.
4. Lotem J., Sachs L. Epigenetics wins over genetics: induction of differentiation in tumor cells. Semin Cancer Biol 2002, 12(5):339-346.
5. de The H., Chen Z. Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nat Rev Cancer 2010, 10(11):775-783.
6. Mintz B., Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci USA 1975, 72(9):3585-3589.
7. Bissell M.J., Hines W.C. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 2011, 17(3):320-329.
8. Partanen J.I., Nieminen A.I., Makela T.P., Klefstrom J. Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization. Proc Natl Acad Sci USA 2007, 104(37):14694-14699.
9. Klein G. Toward a genetics of cancer resistance. Proc Natl Acad Sci USA 2009, 106(3):859-863.
10. Stoker M.G., Shearer M., O'Neill C. Growth inhibition of polyoma-transformed cells by contact with static normal fibroblasts. J Cell Sci 1966, 1(3):297-310.
11. Borek C., Sachs L. The difference in contact inhibition of cell replication between normal cells and cells transformed by different carcinogens. Proc Natl Acad Sci USA 1966, 56(6):1705-1711.
12. Flaberg E., Markasz L., Petranyi G., Stuber G., Dicso F., Alchihabi N., et al. High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts. Int J Cancer 2011, 128(12):2793-2802.
13. Flaberg E., Guven H., Savchenko A., Pavlova T., Kashuba V., Szekely L., et al. The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth. Int J Cancer 2012, 131(10):2274-2283.
14. Bozoky B., Savchenko A., Csermely P., Korcsmaros T., Dul Z., Ponten F., et al. Novel signatures of cancer-associated fibroblasts. Int J Cancer 2013, 133(2):286-293.
15. Uhlen M., Bjorling E., Agaton C., Szigyarto C.A., Amini B., Andersen E., et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 2005, 4(12):1920-1932.
16. Egeblad M., Rasch M.G., Weaver V.M. Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol 2010, 22(5):697-706.
17. Caulin A.F., Maley C.C. Peto's paradox: evolution's prescription for cancer prevention. Trends Ecol Evol 2011, 26(4):175-182.
18. Klein G., Imreh S., Zabarovsky E.R. Why do we not all die of cancer at an early age?. Adv Cancer Res 2007, 98:1-16.
19. Stover D.G., Bierie B., Moses H.L. A delicate balance: TGF-beta and the tumor microenvironment. J Cell Biochem 2007, 101(4):851-861.
20. Oskarsson T., Massague J. Extracellular matrix players in metastatic niches. EMBO J 2012, 31(2):254-256.
21. Erez N., Truitt M., Olson P., Arron S.T., Hanahan D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 2010, 17(2):135-147.
22. Ben-Neriah Y., Karin M. Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol 2011, 12(8):715-723.
23. Schror K. Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer. Best Pract Res Clin Gastroenterol 2011, 25(4-5):473-484.
24. Bissell M.J., Radisky D. Putting tumours in context. Nat Rev Cancer 2001, 1(1):46-54.
25. Harding C., Pompei F., Lee E.E., Wilson R. Cancer suppression at old age. Cancer Res 2008, 68(11):4465-4478.